INS and obesity disorder: In addition, recombinant OCN injection improved glucose tolerance, insulin expression in β-cells, increased β-cell proliferation and insulin secretion, augmented adiponectin expression, decreased fat mass, and prevented high fat diet-induced obesity and diabetes in WT mice (176, 197).